Latest News and Press Releases
Want to stay updated on the latest news?
-
NASDAQ OMX Stockholm decides to officially list 1 bond loan(s) issued by Postnord AB with effect from 2014-04-01. The instrument(s) will be listed on STO Corporate Bonds. Please find instrument...
-
Ar šo informējam, ka IPAS “SEB Wealth Management” vienīgais akcionārs 2014. gada 25. martā pieņēma lēmumu, ar kuru tika ievēlēta padome jaunā sastāvā. IPAS “SEB Wealth Management” padomē...
-
BERLIN, March 31, 2014 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra: MF6), a leading medical technology company in the area of nanotechnology which focuses on oncology, today announced the...
-
Skælskør, 2014-03-31 09:33 CEST (GLOBE NEWSWIRE) -- Harboes Bryggeri A/S Meddelelse om offentliggørelse af opdateret finanskalender for 2014/2015....
-
I medfør af lov om værdipapirhandel § 27a, stk. 1 oplyser LR Realkredit A/S hermed om ekstraordinære indfrielser (CK93) pr. den 28. marts 2014. Oplysningerne fremgår af vedlagte...
-
Le 31 mars 2014 ACTEOS : Eligibilité PEA-PME La société Acteos dont les titres sont cotés sur le NYSE Euronext compartiment C (FR0000076861EOS) entre dans les critères fixés par le législateur,...
-
Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP - a company of EQS...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} EAM: Update on the P31 portfolio acquisition...
-
Clearing Reports are now available. Apologies for the inconvenience. For further clearing information please contact: Clearing Operations + 46 8 405...
-
Copenhagen, 2014-03-31 09:14 CEST (GLOBE NEWSWIRE) -- This year’s summit “How can pharma companies boost preclinical trial success” is chaired by Zealand’s Chief Scientific Officer, Dr. Torsten...